Adherence to highly active antiretroviral therapy in depressed patients with HIV/AIDS attending a Nigerian university teaching hospital clinic.
OBJECTIVE
To determine the prevalence of depressive disorder in patients with HIV/AIDS receiving HAART; to determine the effect of depressive disorder on adherence to antiretroviral therapy; and to determine the significance of the association.


METHODS
The study was conducted amongst outpatients of Ahmadu Bello University Teaching Hospital, Zaria. A sociodemographic and drug adherence questionnaire was administered. The Centre for Epidemiological Studies Depression Scale (CES-D) was used to screen for depressive symptoms while the Schedule for Clinical Assessment in Neuropsychiatry (SCAN) was used to confirm the diagnosis of depressive disorder.


RESULTS
A total of 310 patients with HIV/AIDS receiving HAART participated in the study. 68.4% were female and the mean age was 35.5 (± 8.97 years). 37.4% had secondary education, while 27.1% had tertiary education. Sixty-six participants (21.3%) had significant depressive symptoms while 14.2% met ICD-10 diagnostic criteria for depressive disorder. Overall, 73% of participants had good adherence to HAART. 63.6% of participants with depressive disorder had poor adherence to HAART compared to 21.1% of participants without depressive disorder (p<0.05).


CONCLUSIONS
Depressive disorder in patients with HIV/AIDS is associated with poor adherence to antiretroviral medication. Early identification and treatment of depression in such patients may improve antiretroviral medication adherence and treatment outcomes.
Olisah
V O
VO
Department of Psychiatry, Ahmadu Bello University Teaching Hospital, Zaria, Nigeria. olisahvictor@yahoo.com
Baiyewu
O
O
Sheikh
T L
TL
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy / Q000523:psychology*; D000328:Adult; D023241:Antiretroviral Therapy, Highly Active / Q000523:psychology*; D003863:Depression / Q000175:diagnosis* / Q000188:drug therapy; D003866:Depressive Disorder / Q000175:diagnosis* / Q000188:drug therapy; D005260:Female; D006679:HIV Seropositivity / Q000188:drug therapy / Q000523:psychology*; D006785:Hospitals, University; D006801:Humans; D008297:Male; D009549:Nigeria; D010349:Patient Compliance / Q000523:psychology*; D015995:Prevalence; D011569:Psychiatric Status Rating Scales; D012737:Sex Factors; D011795:Surveys and Questionnaires